Solasia Pharma KK (4597.T)
4597.T on Tokyo Stock Exchange
306JPY
22 Jun 2018
306JPY
22 Jun 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
¥306
¥306
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
2,065,138
2,065,138
52-wk High
¥510
¥510
52-wk Low
¥287
¥287
About
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing... (more)
No analyst recommendations are available for .
Overall
| Beta: | -- |
| Market Cap(Mil.): | ¥29,134.29 |
| Shares Outstanding(Mil.): | 87.75 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| 4597.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.95 | 32.74 |
| EPS (TTM): | -15.68 | -- | -- |
| ROI: | -- | 14.84 | 14.38 |
| ROE: | -- | 16.34 | 16.08 |
BRIEF-Solasia Pharma says termination of clinical trials phase 1 of SP-04
* Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability
Earnings vs. 
Estimates